ethyl tert-butyl ether has been researched along with Experimental Hepatoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banton, MI; Borghoff, SJ; Leavens, TL; Ring, C | 1 |
Doi, Y; Fukushima, S; Furukawa, F; Hagiwara, A; Imai, N; Kawabe, M; Nagano, K; Nakashima, H; Ono, T; Tamano, S | 1 |
2 other study(ies) available for ethyl tert-butyl ether and Experimental Hepatoma
Article | Year |
---|---|
Physiologically based pharmacokinetic model for ethyl tertiary-butyl ether and tertiary-butyl alcohol in rats: Contribution of binding to α2u-globulin in male rats and high-exposure nonlinear kinetics to toxicity and cancer outcomes.
Topics: Administration, Inhalation; Administration, Oral; Alpha-Globulins; Animals; Area Under Curve; Carcinogens; Computer Simulation; Ethyl Ethers; Female; Inhalation Exposure; Kidney; Liver Neoplasms, Experimental; Male; Metabolic Networks and Pathways; Nonlinear Dynamics; Protein Binding; Rats; tert-Butyl Alcohol | 2017 |
Medium-term multi-organ carcinogenesis bioassay of ethyl tertiary-butyl ether in rats.
Topics: Adenocarcinoma; Adenoma, Liver Cell; Animals; Carcinogens; Cocarcinogenesis; Colonic Neoplasms; Ethyl Ethers; Kidney Neoplasms; Liver Neoplasms, Experimental; Male; Random Allocation; Rats; Rats, Inbred F344; Thyroid Neoplasms | 2011 |